ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 109 filers reported holding ALX ONCOLOGY HLDGS INC in Q4 2021. The put-call ratio across all filers is 3.95 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,000 | -43.3% | 3,680 | -8.0% | 0.00% | – |
| Q2 2023 | $30,000 | +500.0% | 4,001 | +226.6% | 0.00% | – |
| Q1 2023 | $5,000 | -83.9% | 1,225 | -55.6% | 0.00% | – |
| Q4 2022 | $31,000 | +1450.0% | 2,762 | +958.2% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 261 | +117.5% | 0.00% | – |
| Q2 2022 | $1,000 | -94.4% | 120 | -89.0% | 0.00% | – |
| Q1 2022 | $18,000 | -73.1% | 1,089 | -65.2% | 0.00% | – |
| Q4 2021 | $67,000 | +737.5% | 3,133 | +2800.9% | 0.00% | – |
| Q3 2021 | $8,000 | +700.0% | 108 | +369.6% | 0.00% | – |
| Q2 2021 | $1,000 | -99.0% | 23 | -98.3% | 0.00% | – |
| Q1 2021 | $99,000 | +4850.0% | 1,347 | +5080.8% | 0.00% | – |
| Q4 2020 | $2,000 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
| Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
| Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
| Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
| Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
| Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
| Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
| Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
| Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |